Filter by: patients
Home > Community Treatment Reports and Side Effects > dorzolamide ophthalmic Treatment Report
What is dorzolamide ophthalmic?

Dorzolamide ophthalmic is an antiglaucoma ophthalmic agent and a carbonic anhydrase inhibitor. It is used for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Blurry vision 1 0
Glaucoma 1 0

See all 2 patients currently taking dorzolamide ophthalmic

Mouse over the table for more information

Reported Dosages

  2 other daily 6 g daily
  1 Number of Patients: 1 1 Number of Patients: 1  

Reported Duration See details about how long patients take this treatment ▼

Currently Taking dorzolamide ophthalmic

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 26, 2012.